Pharmosa Biopharm Inc.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

www.pharmosa.com.tw

Country

Taiwan

Exchange

Taipei Exchange

Founded 2000Taipei, Taiwan

Pharmosa Biopharm Inc., a biotechnology company focuses on developing drugs in Taiwan. It develops L606, an inhalation/device combination for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease

L608, an inhalation/device combination for the treatment of pulmonary vascular disease. Founded in 2000 and headquartered in Taipei, Taiwan, Pharmosa Biopharm was formerly known as Pharmosa Limited before rebranding in October 2016.

Key Stats

52-Week Range

NT$32.50NT$65.00

Beta0.15

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-2.97

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.